Theranostics. 2014; 4(9): 893–903. Colorectal cancer is a serious complication associated with inflammatory bowel disease, often...

Am J Nucl Med Mol Imaging. 2015; 5(4): 379–389. After initial therapy and total resection of glioblastoma multiforme (GBM), 80-90% of...

Clin Cancer Res; 23(12); 3053-60. Purpose: Evaluate 18F-fluoroestradiol (FES) PET/CT as a biomarker of estrogen receptor (ER) occupancy...

Am J Nucl Med Mol Imaging. 2017; 7(2): 53–62. This prospective pilot study provides a dynamic whole body PET/MR image database, clinical...

Nat Commun. 2017 Jun 8;8:15761. Lorlatinib (PF-06463922) is a next-generation small-molecule inhibitor of the orphan receptor tyrosine...

J Nuclear Med. 2018 Apr;20(2):300-308. Purpose: Tremendous efforts are currently dedicated to the development of novel therapies...

Mol Imaging Biol. 2018 Apr;20(2):300-308. HER3 (ERBB3) is a receptor tyrosine kinase that is implicated in treatment resistance across...

J Nucl Med. 2016 Sep;57(9):1413-9. Purpose: Inhibitors of the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of...

Mol Imaging Biol. 2021 Jun 8. Purpose: Standard therapy for HER2+ breast cancers includes HER2 inhibition. While HER2 inhibitors have...

Front Oncol. 2020 Nov 20;10:554704. Triple Negative Breast Cancer (TNBC) is an aggressive form of Breast Cancer (BC). Numerous kinase...

Theranostics. 2016 Sep 9;6(12):2028-2038. Purpose: To assess optical imaging of Mesenchymal-Epithelial Transition factor (MET) for...

Theranostics. 2018 May 23;8(12):3380-3391. Purpose: Reporter gene systems can serve as therapy targets. However, the therapeutic use of...

Clin Cancer Res. 2015 Mar 15;21(6):1340-7. Purpose: Estrogen receptor (ER) targeting is key in management of receptor-positive breast...

Cancer Res. 2013 Dec 1;73(23):6865-73. Somatostatin receptors (SSTR) are highly expressed in well-differentiated neuroendocrine tumors...